Table 1.
Clinical features, culture data and values of 1→3-β-d-glucan (BDG) and Candida mannan (CM) antigen for 15 patients, timing of documented candidemia.
| Patient no. | Age/Gender | Underlying condition | Isolates | BDG (pg/mL) | CM (ng/mL) |
|---|---|---|---|---|---|
| 1 | 25 days/M | ELBW (825 g) | C. albicans | >523 | 1.70 |
| 2 | 75 days/M | ELBW (535 g) | C. parapsilosis | >523 | <0.25 |
| 3 | 25 days/M | VLBW (1065 g) | C. albicans | 276 | 1.88 |
| 4 | 20 days/M | VLBW (1010 g) | C. albicans | 312 | 1.60 |
| 5 | 103 days/M | VLBW (1145 g) | C. albicans | >523 | 1.53 |
| 6 | 9 days/F | VLBW (1200 g) | C. parapsilosis | >523 | <0.25 |
| 7 | 11 days/F | VLBW (1255 g) | C. parapsilosis | >523 | <0.25 |
| 8 | 120 days/M | LBW (1600 g) | C. albicans | 190 | 1.37 |
| 9 | 120 days/M | LBW (1570 g) | C. albicans | 230 | 1.05 |
| 10 | 145 days/M | LBW (1600 g) | C. glabrata | 183 | 1.50 |
| 11 | 13 years/M | NHL | C. albicans | 98 | <0.25 |
| 12 | 11 years/M | ALL | C. albicans | 100 | 1.15 |
| 13 | 5 years/F | AML | C. parapsilosis | 310 | <0.25 |
| 14 | 2 years/F | ALL | C. parapsilosis | 222 | <0.25 |
| 15 | 2 years/M | ALL | C. lusitaniae | 135 | 0.71 |
BDG, (1→3) β-d-glucan; CM, Candida mannan; M, male; F, female; ELBW, Extremely Low Birth Weight (≤1000 g); VLBW, Very Low Birth Weight (1001–1500 g); LBW, Low Birth Weight (1501–2500 g); ALL, acute lymphoid leukemia; AML, acute myeloid leukaemia; NHL, non-Hodgkin’s lymphoma.